Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Buys Ferrosan Consumer Unit, Expands In Russia And Northern Europe

This article was originally published in The Tan Sheet

Executive Summary

Pfizer expands its distribution in the Nordic states and Russia markets with the acquisition of the Danish firm Ferrosan's consumer health care unit.

You may also be interested in...



Pfizer Builds Nutrition Site To Grow Vitamin Business

The website nutritionpossible.com is Pfizer’s latest effort to improve its consumer segment, including the Centrum vitamins line. The site also offers a health assessment tool for recommending supplements and lifestyle changes to consumers.

Pfizer Builds Nutrition Site To Grow Vitamin Business

The website nutritionpossible.com is Pfizer’s latest effort to improve its consumer segment, including the Centrum vitamins line. The site also offers a health assessment tool for recommending supplements and lifestyle changes to consumers.

In Brief

Pharma vets acquire Nutrition 21 assets; FDA approves Perrigo’s generic Mucinex; Pfizer closes Ferrosan consumer health deal; DEA allows PSE log flexibility; and more OTC drug and nutritional product market news In Brief

Related Content

Topics

UsernamePublicRestriction

Register

PS104868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel